Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial

Device-detected subclinical atrial fibrillation (AF) refers to infrequent, short-lasting, asymptomatic AF that is detected only with long-term continuous monitoring. Subclinical AF is common and associated with an increased risk of stroke; however, the risk of stroke with subclinical AF is lower tha...

Full description

Saved in:

Bibliographic Details
Published in:	The American heart journal Vol. 189; pp. 137 - 145
Main Authors:	Lopes, Renato D., Alings, Marco, Connolly, Stuart J., Beresh, Heather, Granger, Christopher B., Mazuecos, Juan Benezet, Boriani, Giuseppe, Nielsen, Jens C., Conen, David, Hohnloser, Stefan H., Mairesse, Georges H., Mabo, Philippe, Camm, A. John, Healey, Jeffrey S.
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01.07.2017 Elsevier Limited
Subjects:	Administration, Oral Aged Anticoagulants Aspirin Atrial Fibrillation - complications Atrial Fibrillation - diagnosis Atrial Fibrillation - therapy Cardiac arrhythmia Cardiovascular Cerebral infarction Clinical trials Dose-Response Relationship, Drug Double-Blind Method EKG Electrocardiography Embolism Embolisms Factor Xa Inhibitors - administration & dosage Female Fibrillation Follow-Up Studies Heart Heart diseases Humans Infarction Ischemia Magnetic resonance imaging Male Middle Aged Mortality Pacemaker, Artificial Patients Prevention Prospective Studies Pyrazoles - administration & dosage Pyridones - administration & dosage Randomization Risk analysis Risk factors Stroke Thromboembolism Thromboembolism - etiology Thromboembolism - prevention & control Transient ischemic attack Trends
ISSN:	0002-8703, 1097-6744, 1097-6744
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!